Literature DB >> 6539459

Supraventricular tachycardia. A probable complication of platinum treatment.

L A Hashimi, M F Khalyl, P A Salem.   

Abstract

A 51-year-old woman with carcinoma of the ovary developed two episodes of supraventricular tachycardia during two consecutive cycles of combination chemotherapy. Both episodes occurred on day 5 of the 5-day continuous infusion schedule of cis-platinum. Underlying causes known to produce supraventricular tachycardia were ruled out. The possibility of platinum-related cardiac toxicity is discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6539459     DOI: 10.1159/000225817

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  6 in total

Review 1.  Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention.

Authors:  V B Pai; M C Nahata
Journal:  Drug Saf       Date:  2000-04       Impact factor: 5.606

Review 2.  Cardiotoxicity of cancer chemotherapy: implications for children.

Authors:  Valeriano C Simbre; Sarah A Duffy; Gul H Dadlani; Tracie L Miller; Steven E Lipshultz
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

3.  The ex vivo neurotoxic, myotoxic and cardiotoxic activity of cucurbituril-based macrocyclic drug delivery vehicles.

Authors:  Rabbab Oun; Rafael S Floriano; Lyle Isaacs; Edward G Rowan; Nial J Wheate
Journal:  Toxicol Res (Camb)       Date:  2014-11-01       Impact factor: 3.524

Review 4.  Cisplatin overdose: toxicities and management.

Authors:  Roger Y Tsang; Turki Al-Fayea; Heather-Jane Au
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

5.  Influence on erythropoietin levels of treatment with cisplatinum-endoxan.

Authors:  W Lechner; E Artner-Dworzak; E Sölder; M Sachsenmaier; D Kölle; H Moncayo; R Reitsamer
Journal:  Arch Gynecol Obstet       Date:  1992       Impact factor: 2.344

6.  Review of cardiotoxicity in pediatric cancer patients: during and after therapy.

Authors:  Joy M Fulbright
Journal:  Cardiol Res Pract       Date:  2011-05-23       Impact factor: 1.866

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.